Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · Real-Time Price · USD
13.14
-0.13 (-0.98%)
Apr 14, 2026, 4:00 PM EDT - Market closed

Dr. Reddy's Laboratories Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
10,98310,97412,2199,4639,25210,176
Market Cap Growth
-0.77%-10.19%29.13%2.27%-9.07%-
Enterprise Value
10,86110,87811,6058,8168,79110,176
Last Close Price
13.1413.1914.6811.3911.1512.28
PE Ratio
17.4416.6318.2817.2829.8743.36
PS Ratio
2.852.883.653.163.283.93
PB Ratio
2.632.813.613.373.66-
P/TBV Ratio
0.030.030.040.040.05-
P/FCF Ratio
27.8949.5635.0916.3552.2328.69
P/OCF Ratio
15.6420.2022.4213.2124.9920.86
EV/Sales Ratio
2.822.863.472.953.113.93
EV/EBITDA Ratio
11.5110.4611.7410.3816.1620.09
EV/EBIT Ratio
14.6912.9414.2812.6822.6430.68
EV/FCF Ratio
27.5849.1333.3315.2449.6228.69
Debt / Equity Ratio
0.160.1400.040-
Debt / EBITDA Ratio
0.810.53-0.19--
Debt / FCF Ratio
1.852.47-0.28--
Net Debt / Equity Ratio
-0.04-0.03-0.18-0.21-0.18-
Net Debt / EBITDA Ratio
-0.18-0.12-0.62-0.69-0.85-
Net Debt / FCF Ratio
-0.40-0.59-1.76-1.02-2.60-
Asset Turnover
0.660.740.790.791.44-
Inventory Turnover
1.812.012.062.143.95-
Quick Ratio
1.171.141.711.561.15-
Current Ratio
1.881.922.592.381.82-
Return on Equity (ROE)
16.10%18.47%21.69%21.30%24.53%-
Return on Assets (ROA)
9.46%12.15%14.77%13.78%14.46%-
Return on Invested Capital (ROIC)
11.97%14.53%18.38%17.20%16.39%-
Return on Capital Employed (ROCE)
17.01%21.92%25.62%26.22%29.50%-
Earnings Yield
5.73%6.01%5.47%5.79%3.35%2.31%
FCF Yield
3.59%2.02%2.85%6.11%1.91%3.49%
Dividend Yield
0.54%0.71%0.65%0.64%0.59%0.56%
Payout Ratio
9.46%11.78%11.94%11.05%17.59%24.06%
Buyback Yield / Dilution
0.15%-0.08%-0.19%-0.03%-0.01%-
Total Shareholder Return
0.69%0.63%0.46%0.61%0.58%0.56%
Updated Jan 21, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q